TLX3 and acute lymphoblastic leukemia: In human T-ALL, it undergoes translocations alternatively activating TLX3 or NKX2-5, but it may also act as a tumor suppressor gene undergoing loss-of-function mutations and/or deletions in 13% and 3% of T-ALL and ETP-ALL, respectively.